Celldex Therapeutics (CLDX) Gross Profit Growth (1y) (2011 - 2026)
Celldex Therapeutics (CLDX) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 68.41% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 33.01% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -41.93% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 57.16% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 351.57% |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | -215.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -215.85% |
| Mar 31, 2026 | 2.04% |
| Dec 31, 2025 | -152.16% |
| Sep 30, 2025 | -149.93% |
| Jun 30, 2025 | -192.19% |
| Mar 31, 2025 | -27.86% |
| Dec 31, 2013 | 545.83% |
| Sep 30, 2013 | 815.89% |
| Jun 30, 2013 | -28.68% |
| Mar 31, 2013 | -10.11% |
| Dec 31, 2012 | 28.00% |
| Sep 30, 2012 | 137.78% |
| Jun 30, 2012 | 1,136.36% |
| Mar 31, 2012 | 535.71% |
| Dec 31, 2011 | 100.79% |
| Sep 30, 2011 | 124.86% |
| Jun 30, 2011 | 106.11% |